Join the Baltimore Chapter of the International Society of Certified Employee Benefit Specialists (“ISCEBS”)
Speaker: Ryan Siemers, CEBS, Principal, Aegis Risk LLC, Alexandria, Virginia.
With the removal of annual and lifetime dollar limits under the ACA, life preserving therapies for rare disease not previously treatable or financially viable can carry six and seven figure annual costs. Their rarity stymies purchasing programs, effective PPO discounts and wellness programs. The financial risks to health plan sponsors, particularly those that self-insure, are significant. If it is an ongoing annual therapy, an unreserved future liability can be several millions of dollars. Risk management in the form of stop loss is being tested as never before, and increasingly applicable to plan sponsors of all sizes.
Ample time will be provided for question from attendees.
Cancellation Policy: There will be no refunds for cancellations received after Tuesday, February 19th.
Ryan Siemers, CEBS
Aegis Risk LLC
Ryan Siemers is a Principal at Aegis Risk LLC, focusing on medical stop loss and the risk management of catastrophic medical claimants. He has performed numerous medical stop-loss analyses for private and public employers throughout the United States. Ryan is the author of the annual Aegis Risk Medical Stop-Loss Premium Survey, done in conjunction with the International Society of Certified Employee Benefit Specialists (ISCEBS). With over 25 years of employee benefits experience, he has previously served as a health and welfare consultant and an underwriter prior to forming Aegis Risk in 2005. Ryan has a bachelor of arts degree in economics from Baylor University and a master’s degree in business administration from the University of Florida. He is a Certified Employee Benefit Specialist (CEBS) and Secretary/Treasurer of the ISCEBS Governing Council.